BYSI

BeyondSpring (BYSI)

BeyondSpring Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BYSI

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/16	21 : 00	GlobeNewswire Inc.	BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics	NASDAQ:BYSI	BeyondSpring Inc
2024/05/03	20 : 00	GlobeNewswire Inc.	BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics	NASDAQ:BYSI	BeyondSpring Inc
2024/04/30	06 : 30	GlobeNewswire Inc.	BeyondSpring Files 2023 Annual Report on Form 20-F	NASDAQ:BYSI	BeyondSpring Inc
2024/04/30	06 : 30	GlobeNewswire Inc.	BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results	NASDAQ:BYSI	BeyondSpring Inc
2024/03/25	20 : 00	GlobeNewswire Inc.	BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer	NASDAQ:BYSI	BeyondSpring Inc
2024/02/26	22 : 01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BYSI	BeyondSpring Inc
2024/02/26	22 : 00	GlobeNewswire Inc.	BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing Requirements	NASDAQ:BYSI	BeyondSpring Inc
2024/02/15	06 : 30	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BYSI	BeyondSpring Inc
2024/02/03	06 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BYSI	BeyondSpring Inc
2024/01/17	06 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BYSI	BeyondSpring Inc
2024/01/11	05 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BYSI	BeyondSpring Inc
2024/01/11	05 : 00	GlobeNewswire Inc.	BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K	NASDAQ:BYSI	BeyondSpring Inc
2023/12/19	06 : 31	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BYSI	BeyondSpring Inc
2023/12/19	06 : 30	GlobeNewswire Inc.	BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements	NASDAQ:BYSI	BeyondSpring Inc
2023/11/07	21 : 00	GlobeNewswire Inc.	BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of Plinabulin Inducing Dendritic Cell Maturation and Re-sensitization in Immunotherapy Refractory Tumors when Combined with Radiation and PD-1/PD-L1 Inhibitors	NASDAQ:BYSI	BeyondSpring Inc
2023/10/31	21 : 00	GlobeNewswire Inc.	BeyondSpring and Professor K. Eisenmann of the University of Toledo College of Medicine Present Poster Highlighting Plinabulin’s Anti-cancer Efficacy in Primary and Recurrent Glioblastoma Patient Derived Invasive Neurosphere Models	NASDAQ:BYSI	BeyondSpring Inc
2023/10/30	21 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BYSI	BeyondSpring Inc
2023/10/30	21 : 00	GlobeNewswire Inc.	BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price Requirement	NASDAQ:BYSI	BeyondSpring Inc
2023/10/26	21 : 30	GlobeNewswire Inc.	SEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at “Targeted Protein Degradation Think Tank” Symposium	NASDAQ:BYSI	BeyondSpring Inc
2023/10/23	20 : 45	GlobeNewswire Inc.	SEED Therapeutics, a BeyondSpring Subsidiary, Appoints Mr. Ko-Yung Tung to the Board of Directors	NASDAQ:BYSI	BeyondSpring Inc
2023/10/05	05 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BYSI	BeyondSpring Inc
2023/10/05	04 : 55	GlobeNewswire Inc.	BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements	NASDAQ:BYSI	BeyondSpring Inc
2023/09/27	23 : 00	GlobeNewswire Inc.	BeyondSpring and Leading Cancer Center to Present Poster at SITC’s 38th Annual Meeting	NASDAQ:BYSI	BeyondSpring Inc
2023/09/21	06 : 20	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BYSI	BeyondSpring Inc
2023/09/07	21 : 00	GlobeNewswire Inc.	BeyondSpring to Participate in the R.W. Baird’s 2023 Global Healthcare Conference	NASDAQ:BYSI	BeyondSpring Inc
2023/07/15	05 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BYSI	BeyondSpring Inc
2023/06/20	21 : 00	GlobeNewswire Inc.	SEED Therapeutics, BeyondSpring Subsidiary, Appoints Jackson Tai to Board of Directors	NASDAQ:BYSI	BeyondSpring Inc
2023/06/07	21 : 00	GlobeNewswire Inc.	BeyondSpring and Leading Cancer Center Present Poster Highlighting Plinabulin’s Ability to Reduce Infectious Neutropenic Fever for Multiple Myeloma Patients Undergoing AHCT	NASDAQ:BYSI	BeyondSpring Inc
2023/05/18	21 : 30	GlobeNewswire Inc.	BeyondSpring and Leading Cancer Center to Present Poster at 2023 ASCO Annual Meeting	NASDAQ:BYSI	BeyondSpring Inc
2023/05/13	05 : 31	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:BYSI	BeyondSpring Inc